We are live on ! Find out more
CI

CX Institutional Portfolio holdings

AUM $3.46B
1-Year Est. Return 21.89%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+21.89%
3 Year Est. Return
+56.76%
5 Year Est. Return
+57.8%
10 Year Est. Return
AUM
$630M
AUM Growth
+$63M
Cap. Flow
+$49.5M
Cap. Flow %
7.86%
Top 10 Hldgs %
27.33%
Holding
1,003
New
225
Increased
423
Reduced
211
Closed
62

Sector Composition

Rank Sector Weight
1 Financials 6.07%
2 Consumer Discretionary 4.5%
3 Industrials 3.29%
4 Consumer Staples 3.08%
5 Healthcare 2.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
151
Amazon
AMZN
$2.51T
$587K 0.09%
6,200
+780
+14% +$72.7K
BRO icon
152
Brown & Brown
BRO
$22.3B
$584K 0.09%
17,436
-953
-5% -$30.2K
WTMF icon
153
WisdomTree Managed Futures Strategy Fund
WTMF
$238M
$581K 0.09%
15,385
+7,758
+102% +$301K
RVTY icon
154
Revvity
RVTY
$12.6B
$580K 0.09%
6,019
-7
-0.1% -$652
QAI icon
155
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.01B
$570K 0.09%
18,736
+9,280
+98% +$280K
JPMF
156
DELISTED
JPMorgan Managed Futures Strategy ETF
JPMF
$569K 0.09%
23,498
+11,619
+98% +$279K
CI icon
157
Cigna
CI
$75.7B
$561K 0.09%
3,563
+40
+1% +$6.27K
JPHF
158
DELISTED
JPMorgan Diversified Alternatives ETF
JPHF
$559K 0.09%
22,880
+11,468
+100% +$282K
AGGY icon
159
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$923M
$558K 0.09%
10,899
+1,145
+12% +$57.5K
OXY icon
160
Occidental Petroleum
OXY
$57.3B
$528K 0.08%
10,500
-5
-0% -$281
IJH icon
161
iShares Core S&P Mid-Cap ETF
IJH
$122B
$527K 0.08%
+13,570
New +$520K
V icon
162
Visa
V
$669B
$518K 0.08%
2,982
+299
+11% +$49K
MRK icon
163
Merck
MRK
$322B
$507K 0.08%
6,338
+715
+13% +$54.7K
IJR icon
164
iShares Core S&P Small-Cap ETF
IJR
$109B
$479K 0.08%
6,119
+5,891
+2,584% +$457K
CIBR icon
165
First Trust NASDAQ Cybersecurity ETF
CIBR
$13.7B
$451K 0.07%
15,777
+4,927
+45% +$140K
CRL icon
166
Charles River Laboratories
CRL
$11B
$442K 0.07%
3,114
+14
+0.5% +$1.9K
CSCO icon
167
Cisco
CSCO
$444B
$442K 0.07%
8,073
+3,047
+61% +$168K
LLY icon
168
Eli Lilly
LLY
$1.06T
$441K 0.07%
3,985
+427
+12% +$50.3K
META icon
169
Meta Platforms (Facebook)
META
$1.54T
$430K 0.07%
2,226
+387
+21% +$70.7K
SHW icon
170
Sherwin-Williams
SHW
$76.6B
$429K 0.07%
2,811
+9
+0.3% +$1.34K
ADP icon
171
Automatic Data Processing
ADP
$97.1B
$409K 0.06%
2,472
+73
+3% +$11.9K
DOV icon
172
Dover
DOV
$26.6B
$394K 0.06%
3,935
STT icon
173
State Street
STT
$50.6B
$392K 0.06%
6,998
-27,505
-80% -$1.71M
AGN
174
DELISTED
Allergan plc
AGN
$387K 0.06%
2,313
-18
-0.8% -$2.49K
VEA icon
175
Vanguard FTSE Developed Markets ETF
VEA
$226B
$363K 0.06%
8,711
+1,717
+25% +$70.8K

Similar funds

CX Institutional's Q2 2019 Portfolio in Review

As of Q2 2019, CX Institutional held 1,003 positions worth $630M, up 11% from $567M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

CX Institutional deployed $49.5M of net new capital in Q2 2019, opening 225 new positions and adding to 423 existing holdings. Its largest new stake was State Street SPDR US Large Cap Low Volatility Index ETF: 99,589 shares worth $10.7M.

By sector, the portfolio is most concentrated in Financials at 6.1% of assets, down from 7.8% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was JPMorgan Ultra-Short Income ETF, an estimated $7.12M trimmed.

  • CX Institutional's largest Q2 2019 buy was State Street SPDR US Large Cap Low Volatility Index ETF: 99,589 shares worth $10.7M.
  • CX Institutional added most to iShares Core S&P Total US Stock Market ETF in Q2 2019, an estimated $19.1M increase.
  • CX Institutional's biggest Q2 2019 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $7.12M.
  • CX Institutional fully exited Phillips 66 in Q2 2019, selling an estimated $6.37M.
  • CX Institutional's ten largest holdings make up 27% of its $630M portfolio in Q2 2019.
  • CX Institutional opened 225 new positions and closed 62 in Q2 2019.
  • CX Institutional's portfolio value rose 11% quarter-over-quarter to $630M.

Based on CX Institutional's 13F filing for Q2 2019, filed 17 Jul 2019.